All Stories

  1. Population structure of Mycobacterium avium subsp. hominissuis provides new insights into genomic evolution
  2. Social Determinants and Community-Level Risk Factors in CA-MRSA Transmission Among Disadvantaged Populations in North America: A Scoping Review
  3. Genomic Epidemiology of Mycobacterium abscessus on the Island of Montréal Is Not Suggestive of Health Care-Associated Person-to-Person Transmission
  4. A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics
  5. Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms
  6. Minos: variant adjudication and joint genotyping of cohorts of bacterial genomes
  7. The Dataharmonizer: a Tool for Faster Data Harmonization, Validation, Aggregation, and Analysis of Pathogen Genomics Contextual Information
  8. A crowd of BashTheBug volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth microdilution plates
  9. The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
  10. Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing ofM. tuberculosis
  11. Highly divergent white-tailed deer SARS-CoV-2 with potential deer-to-human transmission
  12. Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern
  13. Characteristics of SARS-CoV-2 testing for rapid diagnosis of COVID-19 during the initial stages of a global pandemic
  14. Coronavirus Disease 2019 (COVID-19) Outbreak Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) P.1 Lineage in a Long-Term Care Home After Implementation of a Vaccination Program—Ontario, Canada, April–May 2021
  15. Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada
  16. Adverse Outcomes Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Infection in Vaccinated Residents of a Long-Term Care Home, Ontario, Canada
  17. Detection of the novel SARS-CoV-2 European lineage B.1.177 in Ontario, Canada
  18. Investigation of a severe SARS-CoV-2 outbreak in a long-term care home early in the pandemic
  19. Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada
  20. Detection of the Novel SARS-CoV-2 European Lineage B.1.177 in Ontario, Canada
  21. Using Whole Genome Sequencing to Determine the Timing of Secondary Tuberculosis in British Columbia, Canada
  22. Genomic Epidemiology of Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Hospitalized Individuals in Ontario, Canada
  23. Comparison of routine field epidemiology and whole genome sequencing to identify tuberculosis transmission in a remote setting
  24. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
  25. The problem with defining foreign birth as a risk factor in tuberculosis epidemiology studies
  26. Universal genotyping reveals province-level differences in the molecular epidemiology of tuberculosis
  27. Whole genome sequencing for improved understanding of Mycobacterium tuberculosis transmission in a remote circumpolar region
  28. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
  29. Genotyping and Whole Genome Sequencing to Identify Tuberculosis Transmission to Pediatric Patients in British Columbia, Canada, 2005–2014
  30. Universal Genotyping for Tuberculosis Prevention Programs: a 5-Year Comparison with On-Request Genotyping
  31. Molecular Epidemiology of Tuberculosis in British Columbia, Canada: A 10-Year Retrospective Study
  32. WGS virulence factor typing for pertussis
  33. Self-rated health and reasons for non-vaccination against seasonal influenza in Canadian adults with asthma
  34. A brief primer on genomic epidemiology: lessons learned fromMycobacterium tuberculosis
  35. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
  36. Technology and tuberculosis control: the OUT-TB Web experience
  37. Accelerating tuberculosis elimination in low-incidence settings: the role of genomics
  38. Culture-Positive Pediatric Tuberculosis in Toronto, Ontario
  39. Marked Microevolution of a Unique Mycobacterium tuberculosis Strain in 17 Years of Ongoing Transmission in a High Risk Population
  40. Whole-Genome Sequencing of the Mycobacterium tuberculosis Manila Sublineage Results in Less Clustering and Better Resolution than Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat (MIRU-VNTR) Typing and Spoligotyping
  41. Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis
  42. Epidemiological evaluation of spatiotemporal and genotypic clustering of Mycobacterium tuberculosis in Ontario, Canada
  43. Reply to “Role ofrpsAGene Sequencing in Diagnosis of Pyrazinamide Resistance”
  44. Gene Sequencing for Routine Verification of Pyrazinamide Resistance in Mycobacterium tuberculosis: a Role for pncA but Not rpsA
  45. Evaluation of Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat Genotyping as Performed in Laboratories in Canada, France, and the United States
  46. Dispersal of Mycobacterium tuberculosis via the Canadian fur trade
  47. Analytical and clinical validation of novel real-time reverse transcriptase–polymerase chain reaction assays for the clinical detection of swine-origin H1N1 influenza viruses
  48. Crystal structure of a truncated urease accessory protein UreF from Helicobacter pylori
  49. Evaluation of Specificity of BP3385 for Bordetella pertussis Detection
  50. Novel Duplex Real-Time PCR Assay Detects Bordetella holmesii in Specimens from Patients with Pertussis-Like Symptoms in Ontario, Canada
  51. Sequence- and activity-based screening of microbial genomes for novel dehalogenases
  52. Mycobacterium tuberculosis in Ontario, Canada: Insights from IS6110 Restriction Fragment Length Polymorphism and Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat Genotyping
  53. Use of Bordetella pertussis BP3385 To Establish a Cutoff Value for an IS481-Targeted Real-Time PCR Assay
  54. In situ proteolysis for protein crystallization and structure determination
  55. Chitinase production during interaction of Trichoderma aggressivum and Agaricus bisporus
  56. An improved method for detection and quantification of chitinase activities